You are receiving this message since your browser does not support Java Script or you have Java Scripts disabled. The following disclaimer is provided as an alternative to the information that would normally be seen on your monitor when you click on a link to a non-federal site.

"You are now leaving the NIDDK website. The NIDDK is not responsible for the content of web pages found on this linked website. Links to nonfederal organizations are provided solely as a service to our users. These links do not indicate an endorsement of these organizations by NIDDK or the federal government."

Type 1 Diabetes (T1D) Special Statutory Funding Program

Clinical Studies Recruiting Type 1 Diabetes Patients and Family Members

Alphabetical Listing

Please click on the study name for recruitment information or the consortium name to go to the consortium's website.

Clinical Islet Transplantation Consortium (CIT) : The goal of the CIT02 studies is to determine the proportion of subjects who are insulin independent after a single islet cell infusion at 75 ± 5 days post-transplant in subjects treated with Exenatide or Lisofylline added to a standard islet transplant regimen.
Study Names: Strategies to Improve Long Term Islet Graft Survival, B-Lymphocyte Immunotherapy in Islet Transplantation, Efficacy of Islet after Kidney Transplantation , Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes, Islet Transplantation in Type 1 Diabetes with LEA29Y Maintenance Therapy, Islet Transplantation in Type 1 Diabetes

Family Investigation of Nephropathy and Diabetes (FIND) : The main goal of this consortium is to acquire sets of families with well-characterized diabetic nephropathy, in order to perform a genome scan to identify chromosomal regions linked with diabetic nephropathy.
Study Name: Family Investigation of Nephropathy and Diabetes

Search for Diabetes in Youth (SEARCH ) : A population-based registry to define the prevalence and incidence of diabetes in children of diverse racial and ethnic backgrounds by diabetes type.
Study Name: SEARCH for Diabetes in Youth

The Environmental Determinants of Diabetes in the Young (TEDDY) : This study is identifying infants at high-risk for developing type 1 diabetes and following them through adolescence in the search for environmental factors that may trigger disease onset.
Study Name: The Environmental Determinants of Diabetes in the Young

Trial to Reduce IDDM in the Genetically at Risk (TRIGR) : This randomized, double blinded intervention study is comparing the development of type 1 diabetes in infants who are weaned onto a hydrolysate of cow’s milk formula, in which many of the cow proteins have been broken down, versus standard cow’s milk formula.
Study Name: Trial to Reduce IDDM in those at Genetic Risk

Type 1 Diabetes Genetics Consortium (T1DGC) : This consortium is recruiting families in order to develop resources for the scientific community to identify genes influencing an individual’s risk for developing type 1 diabetes.
Study Name: Type 1 Diabetes Genetics Consortium

Type 1 Diabetes TrialNet (TrialNet) : This network supports clinical trials of agents to slow the progression of type 1 diabetes in new-onset patients and to prevent the disease in at-risk patients.
Study Names: TrialNet-MMF/DZB, TrialNet Natural History Study, The Rituximab Study, Nutritional Intervention to Prevent Diabetes , Oral Insulin Study , TEST, test, CTLA-4 Ig (Abatacept) in Recent Onset Diabetes



Last Updated: June 30, 2008

General Inquiries may be addressed to:
Office of Communications and Public Liaison
NIDDK, NIH
Building 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560 USA
For information about NIDDK programs: 301.496.3583